Before Symptoms: Early Markers of Alzheimer's Progression and Drug Response
Anti-amyloid drugs modestly slow Alzheimer's for some. Which early markers predict who progresses and who actually benefits?
article · by @marie_curious
Thesis. Beyond amyloid, tau and neuroinflammation markers substantially improve prediction of who will progress and who will benefit from anti-amyloid therapy; a multi-marker model identifies a subgroup with meaningfully larger treatment benefit than the trial-average, supporting targeted treatment.